Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Checkpoint Therapeutics, Inc. (CKPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
8-K
| Quarterly results |
| 11/08/2022 |
8-K
| Quarterly results |
| 08/12/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 11/04/2021 |
8-K
| Quarterly results |
| 08/05/2021 |
8-K
| Quarterly results |
| 05/06/2021 |
8-K
| Quarterly results |
| 11/04/2020 |
8-K
| Quarterly results|
Docs:
|
"Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights – November 4, 2020 – Checkpoint Therapeutics, Inc. , a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced financial results for the third quarter ended September 30, 2020, and recent corporate highlights. James F. Oliviero, President and Chief Executive Officer of Checkpoint, said, “We are excited to have presented updated positive interim results from the ongoing registration-enabling clinical trial of cosibelimab for the treatment of metastatic cutaneous squamous cell carcinoma at the European Society for Medical Oncology Virtual Congress 2020. T..." |
|
| 08/05/2020 |
8-K
| Quarterly results |
| 05/06/2020 |
8-K
| Quarterly results |
| 11/07/2019 |
8-K
| Quarterly results |
| 08/08/2019 |
8-K
| Quarterly results|
Docs:
|
"CHECKPOINT THERAPEUTICS, INC. CONDENSED BALANCE SHEETS June 30, 2019 December 31, 2018 ASSETS Current Assets: Cash and cash equivalents $ 13,205 $ 21,995 Prepaid expenses and other assets 967 1,372 Other receivables - related party 1,051 1,532 Total current assets 15,223 24,899 Total Assets $ 15,223 $ 24,899 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable and accrued expenses $ 7,093 $ 12,317 Accounts payable and accrued expenses - related party 921 776 Total current liabilities 8,014 13,093 Total Liabilities 8,014 13,093 Commitments and Contingencies Stockholders' Equity Common Stock , 60,000,000 shares authorized Class A common shares, 7,000,000 shares issued and outstanding as of June 30, 2019 and December 31, 2018 1 1 Common shares, 29,960,034 and 27,076,154 ..." |
|
| 05/09/2019 |
8-K
| Quarterly results|
Docs:
|
"CHECKPOINT THERAPEUTICS, INC. CONDENSED BALANCE SHEETS March 31, 2019 December 31, 2018 ASSETS Current Assets: Cash and cash equivalents $ 14,147 $ 21,995 Prepaid expenses and other assets 1,064 1,372 Other receivables - related party 77 1,532 Total current assets 15,288 24,899 Total Assets $ 15,288 $ 24,899 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable and accrued expenses $ 7,407 $ 12,317 Accounts payable and accrued expenses - related party 803 776 Total current liabilities 8,210 13,093 Total Liabilities 8,210 13,093 Commitments and Contingencies Stockholders' Equity Common Stock , 60,000,000 shares authorized Class A common shares, 7,000,000 shares issued and outstanding as of March 31, 2019 and December 31, 2018 1 1 Common shares, 28,881,756 and 27,076,154..." |
|
| 11/02/2018 |
8-K
| Quarterly results|
Docs:
|
"CHECKPOINT THERAPEUTICS, INC. CONDENSED BALANCE SHEETS September 30, 2018 December 31, 2017 ASSETS Current Assets: Cash and cash equivalents $ 29,600 $ 19,225 Prepaid expenses and other assets 1,196 1,857 Other receivables - related party 5 331 Total current assets 30,801 21,413 Total Assets $ 30,801 $ 21,413 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable and accrued expenses $ 8,118 $ 5,762 Accounts payable and accrued expenses - related party 664 610 Total current liabilities 8,782 6,372 Total Liabilities 8,782 6,372 Commitments and Contingencies Stockholders' Equity Common Stock , 60,000,000 shares authorized Class A common shares, 7,000,000 shares issued and outstanding as of September 30, 2018 and December 31, 2017 1 1 Common shares, 26,996,238 and 18,512,4..." |
|
| 05/10/2018 |
8-K
| Quarterly results|
Docs:
|
"CHECKPOINT THERAPEUTICS, INC. BALANCE SHEETS March 31, December 31, 2018 2017 ASSETS Current Assets: Cash and cash equivalents $ 34,863 $ 19,225 Prepaid expenses and other assets 1,222 1,857 Other receivables - related party 344 331 Total current assets 36,429 21,413 Total Assets $ 36,429 $ 21,413 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable and accrued expenses $ 7,000 $ 5,762 Accounts payable and accrued expenses - related party 530 610 Total current liabilities 7,530 6,372 Total Liabilities 7,530 6,372 Commitments and Contingencies Stockholders' Equity Common Stock , 50,000,000 shares authorized Class A common shares, 7,000,000 shares issued and outstanding as of March 31, 2018 and December 31, 2017 1 1 Common shares, 25,015,088 and 18,512,429 shares issued..." |
|
|
|